Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SPIDIA4P

Financiado

Cerrado

SPIDIA for Personalized Medicine Standardisation of generic Pre analytical pro...

SPIDIA for Personalized Medicine Standardisation of generic Pre analytical procedures for In vitro DIAgnostics for Personalized Medicine Molecular in vitro diagnostics and biomedical research have allowed great progress in personalised medicine but further progress is limited by insufficient guidelines for pre-analytical workflow steps (sample collection, preservat... ver más

30/06/2021

QIAGEN GMBH

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

QIAGEN GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 19 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-06-30

SC1-HCO-02-2016: Standardisation of pre-analytical a...

I+D

Cerrada hace 8 años

0% 96% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

19 Participantes

QIAGEN GMBH

381.98K€ | Lider

ERASMUS MC

118.08K€ | Participante

Start Codon Limited

96.45K€ | Participante

INIVATA

16.58K€ | Participante

Proyectos interesantes

VAC2VAC

Medical Technol...

Data Science

16M€ Cerrado

CANCER-ID

Medical Technol...

Data Science

21M€ Cerrado

PERMIT

Medical Technol...

Data Science

2M€ Cerrado

RTC-2016-4707-1

Medical Technol...

Data Science

414K€ Cerrado

PTA2015-11724-I

Medical Technol...

Data Science

36K€ Cerrado

DIA-CHIP

Medical Technol...

Data Science

731K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 55 meses Fecha Inicio: 2016-11-30
Fecha Fin: 2021-06-30

Líder del proyecto

QIAGEN GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Molecular in vitro diagnostics and biomedical research have allowed great progress in personalised medicine but further progress is limited by insufficient guidelines for pre-analytical workflow steps (sample collection, preservation, storage, transport, processing etc.) as well as by insufficient quality assurance of diagnostic practice. This allows using compromised patients’ samples with post collection changes in cellular and extra-cellular biomolecules’ profiles thus often making diagnostic test results unreliable or even impossible. To tackle this, SPIDA4P aims to generate and implement a comprehensive portfolio of 22 pan-European pre-analytical CEN/Technical Specifications and ISO/International Standards, addressing the important pre-analytical workflows applied to personalized medicine. These will also applicable to biomarker discovery, development and validation as well as to biobanks. Corresponding External Quality Assurance (EQA) Schemes will be developed and implemented as well, aiming to survey the resulting quality of samples and diagnostic practice. SPIDIA4P will ensure stakeholder organisations involvements as well as training, education, and counselling as additional major foci of the project. The consortium will closely coordinate with large European public research consortia to obtain access to research and validation studies data serving as evidence for the new standards developments and achieved improvements of diagnosis, patient stratification and prognosis of disease outcome. At this crucial moment in the development of personalised medicine, SPIDIA4P proposes a coordination and support action that reunites 19 highly experienced partners in international standardisation for in vitro diagnostics, coming from private industry including SMEs, public institutions and from one official European Standards Organisation. This strong consortium is balanced and empowered to maximise the impacts of in vitro diagnostics on personalised medicine.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores